Beck Mack & Oliver LLC grew its stake in shares of RadNet Inc. (NASDAQ:RDNT) by 60.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 352,916 shares of the medical research company’s stock after buying an additional 133,515 shares during the quarter. Beck Mack & Oliver LLC’s holdings in RadNet were worth $3,564,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in RDNT. Dimensional Fund Advisors LP lifted its holdings in RadNet by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,531,850 shares of the medical research company’s stock worth $11,872,000 after buying an additional 112,194 shares in the last quarter. Vanguard Group Inc. lifted its holdings in RadNet by 4.2% in the 2nd quarter. Vanguard Group Inc. now owns 1,284,852 shares of the medical research company’s stock worth $9,957,000 after buying an additional 51,229 shares in the last quarter. State Street Corp lifted its holdings in RadNet by 9.2% in the 2nd quarter. State Street Corp now owns 585,218 shares of the medical research company’s stock worth $4,538,000 after buying an additional 49,186 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in RadNet by 85.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 503,880 shares of the medical research company’s stock worth $5,795,000 after buying an additional 232,524 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in RadNet by 5.2% in the 2nd quarter. Northern Trust Corp now owns 436,407 shares of the medical research company’s stock worth $3,382,000 after buying an additional 21,746 shares in the last quarter. 53.24% of the stock is owned by institutional investors.

In related news, insider John V. Crues sold 40,000 shares of the stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $9.90, for a total transaction of $396,000.00. Following the sale, the insider now owns 623,781 shares in the company, valued at $6,175,431.90. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director John V. Crues sold 20,000 shares of the stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $10.08, for a total transaction of $201,600.00. Following the sale, the director now owns 563,781 shares in the company, valued at approximately $5,682,912.48. The disclosure for this sale can be found here. In the last quarter, insiders have sold 133,084 shares of company stock worth $1,321,587. 9.36% of the stock is owned by company insiders.

Shares of RadNet Inc. (RDNT) traded down $0.03 during trading on Friday, hitting $10.02. 24,639 shares of the stock were exchanged, compared to its average volume of 147,386. The firm has a market cap of $483.38 and a price-to-earnings ratio of 33.83. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 7.88. RadNet Inc. has a 1-year low of $5.25 and a 1-year high of $11.90.

RadNet (NASDAQ:RDNT) last issued its earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.12. The business had revenue of $227.60 million for the quarter, compared to analyst estimates of $232.84 million. RadNet had a net margin of 1.21% and a return on equity of 23.73%. The company’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.11 EPS. equities analysts expect that RadNet Inc. will post 0.35 EPS for the current year.

A number of equities analysts have commented on the stock. Zacks Investment Research lowered shares of RadNet from a “buy” rating to a “hold” rating in a report on Wednesday, January 10th. TheStreet lowered shares of RadNet from a “b-” rating to a “c” rating in a research note on Friday, October 27th. Finally, BidaskClub upgraded shares of RadNet from a “sell” rating to a “hold” rating in a research note on Saturday, January 6th.

WARNING: “Beck Mack & Oliver LLC Increases Stake in RadNet Inc. (RDNT)” was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.watchlistnews.com/beck-mack-oliver-llc-increases-stake-in-radnet-inc-rdnt/1839727.html.

RadNet Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet Inc. (NASDAQ:RDNT).

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.